Hospital Acquired Infections Control Market

119

Hospital Acquired Infections Control is expected to be the most lucrative among all product types with an attractiveness index

Greater focus on development of reprocessors exhibiting innovative product design to avoid cross contamination and enhance patient safety coupled with advancements in the medical device industry is expected to create a favorable platform for innovative reprocessing technologies in high-income economies such as the U.K. and U.S. Companies are expected to benefit from increasing incorporation of innovative technologies in AERs. Such systems are expected to revolutionize the cleaning process in the most effective manner in the near future.

Hospitals are gradually shifting from heat sterilization to low temperature sterilization owing to the various drawbacks related to steam heat sterilizers
The disinfection equipment segment is expected to be the most lucrative among all product types with an attractiveness index of 2.14, while the heat sterilization equipment segment is anticipated to be the second attractive segment in the hospital acquired infections control market, with an attractiveness index of 1.78. Disinfection equipment is the largest product type in the global hospital acquired infections control market, which was estimated to represent US$ 2,585.1 Mn, or 49.6% share of the total market in 2017 and is projected to reach a market valuation of US$ 3,852.5 Mn by 2025 end, expanding at a CAGR of 5.1% over the forecast period 2017–2025.

Global Hospital Acquired Infections Control Market: Forecast by Product Type
On the basis of product type, the global hospital acquired infections control market is segmented into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, and disinfection equipment. In terms of revenue, disinfection equipment was the dominant product type in the global hospital acquired infections control market in 2016. In terms of growth, low temperature sterilization equipment is expected to be the fastest growing segment, registering a CAGR of 5.3% over the forecast period.

Global Hospital Acquired Infections Control Market: Forecast by End User
On the basis of end user, the global market for hospital acquired infections control is segmented into hospitals, ambulatory surgery centers, medical institutions, diagnostic laboratories and clinics. Hospitals dominated the global hospital acquired infections control market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Hospitals are expected to be the most lucrative among all end users, with a market attractiveness index of 1.6.

Global Hospital Acquired Infections Control Market: Key Players
Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, Bayer AG, Alere Inc., The 3M Company and Cepheid Inc. are some of the key players operating in the global hospital acquired infections control market.